Lpl Financial LLC Sage Therapeutics, Inc. Transaction History

Lpl Financial LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$40.26 - $57.37 $172,111 - $245,256	-4,275 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$54.88 - $79.29 $11,250 - $16,254	205 Added 5.04%	4,275 $243,000
Q1 2021 May 14, 2021	BUY	$70.65 - $96.76 $15,754 - $21,577	223 Added 5.8%	4,070 $305,000
Q4 2020 Feb 12, 2021	BUY	$58.41 - $89.06 $11,039 - $16,832	189 Added 5.17%	3,847 $333,000
Q3 2020 Nov 09, 2020	BUY	$41.13 - $62.45 $150,453 - $228,442	3,658 New	3,658 $224,000

Q4 2019 Feb 14, 2020	SELL	$60.18 - $154.77 $139,918 - $359,840	-2,325 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$140.29 - $189.96 $47,277 - $64,016	-337 Reduced 12.66%	2,325 $326,000
Q2 2019 Aug 09, 2019	BUY	$157.85 - $183.09 $80,187 - $93,009	508 Added 23.58%	2,662 $487,000
Q1 2019 May 08, 2019	BUY	$89.33 - $163.65 $192,416 - $352,502	2,154 New	2,154 $343,000

223

52.7M

207K

191K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $645M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

Stay updated on Lpl Financial LLC with notifications on news.